These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1680556)

  • 1. The management of the levodopa psychoses.
    Friedman JH
    Clin Neuropharmacol; 1991 Aug; 14(4):283-95. PubMed ID: 1680556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical antipsychotics in the treatment of drug-induced psychosis in Parkinson's disease.
    Friedman JH; Factor SA
    Mov Disord; 2000 Mar; 15(2):201-11. PubMed ID: 10752567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease: drug-induced psychiatric states.
    Factor SA; Molho ES; Podskalny GD; Brown D
    Adv Neurol; 1995; 65():115-38. PubMed ID: 7872135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clozapine in the treatment of adverse psychiatric manifestations of long-term therapy with levodopa].
    Svetel MV; Sternić NM; Filipović SR; Vojvodić NM; Kostić VS
    Srp Arh Celok Lek; 1997; 125(7-8):203-6. PubMed ID: 9304232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combined clozapine and electroconvulsive therapy for the treatment of drug-induced psychosis in Parkinson's disease.
    Factor SA; Molho ES; Brown DL
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):304-7. PubMed ID: 7580188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electroconvulsive therapy in drug-induced psychiatric states and neuroleptic malignant syndrome.
    Ozer F; Meral H; Aydin B; Hanoglu L; Aydemir T; Oral T
    J ECT; 2005 Jun; 21(2):125-7. PubMed ID: 15905757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of ECT in phencyclidine-induced psychosis.
    Rosen AM; Mukherjee S; Shinbach K
    J Clin Psychiatry; 1984 May; 45(5):220-2. PubMed ID: 6144671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuropsychiatric adverse effects of antiparkinsonian drugs. Characteristics, evaluation and treatment.
    Young BK; Camicioli R; Ganzini L
    Drugs Aging; 1997 May; 10(5):367-83. PubMed ID: 9143857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of drug-induced exogenous psychosis in parkinsonism with clozapine and fluperlapine.
    Scholz E; Dichgans J
    Eur Arch Psychiatry Neurol Sci; 1985; 235(1):60-4. PubMed ID: 2864254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of clozapine in Brazilian patients with Parkinson's disease.
    Gomide L; Kummer A; Cardoso F; Teixeira AL
    Arq Neuropsiquiatr; 2008 Sep; 66(3B):611-4. PubMed ID: 18949249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of clozapine to treat levodopa-induced psychosis in Parkinson's disease: retrospective review.
    Widman LP; Burke WJ; Pfeiffer RF; McArthur-Campbell D
    J Geriatr Psychiatry Neurol; 1997 Apr; 10(2):63-6. PubMed ID: 9188021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ziprasidone in Parkinson's disease psychosis.
    Connemann BJ; Schönfeldt-Lecuona C
    Can J Psychiatry; 2004 Jan; 49(1):73. PubMed ID: 14763682
    [No Abstract]   [Full Text] [Related]  

  • 13. Antipsychotics and Parkinson's disease: association with disease and drug choice during the first 5 years of antiparkinsonian drug treatment.
    van de Vijver DA; Roos RA; Jansen PA; Porsius AJ; de Boer A
    Eur J Clin Pharmacol; 2002 May; 58(2):157-61. PubMed ID: 12012150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole and Parkinson's disease psychosis.
    Schönfeldt-Lecuona C; Connemann BJ
    Am J Psychiatry; 2004 Feb; 161(2):373-4. PubMed ID: 14754792
    [No Abstract]   [Full Text] [Related]  

  • 15. The effect of quetiapine on psychosis and motor function in parkinsonian patients with and without dementia.
    Reddy S; Factor SA; Molho ES; Feustel PJ
    Mov Disord; 2002 Jul; 17(4):676-81. PubMed ID: 12210856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosis during chronic levodopa therapy triggered by the new antidepressive drug mirtazapine.
    Normann C; Hesslinger B; Frauenknecht S; Berger M; Walden J
    Pharmacopsychiatry; 1997 Nov; 30(6):263-5. PubMed ID: 9442549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Melperone in the treatment of iatrogenic psychosis in Parkinson's disease.
    Barbato L; Monge A; Stocchi F; Nordera G
    Funct Neurol; 1996; 11(4):201-7. PubMed ID: 8934152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Usefulness of olanzapine in the levodopa-induced psychosis in patients with Parkinson's disease].
    Chacón JR; Durán E; Durán JA; Alvarez M
    Neurologia; 2002 Jan; 17(1):7-11. PubMed ID: 11834192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ziprasidone for drug-induced psychotic symptoms in Parkinson's Disease.
    Duggal HS; Singh I
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):583-4. PubMed ID: 18022304
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.